2026 NPPES data Hematology & Oncology Physician NPI 1013193705 MD
Verify on CMS →

KELLIE FLIPPIN, MD

Hematology & Oncology Physician in QUINCY, Illinois. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
536
Medicare Part D claims · 114 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
73%
generic claims · 27% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$15.29
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

KELLIE FLIPPIN, MD filed 536 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in QUINCY, Illinois, prescribing 73% generic.

536
Part D claims, 2023
73%
generic prescribing
$15.29
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

KELLIE FLIPPIN, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

536 Top 34% higher than 66% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

KELLIE FLIPPIN, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about KELLIE FLIPPIN, MD?

Quality data not reported

NPI registry status

Active

Issued 01/14/2008

NPI 1013193705

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

536 37% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Illinois

How Hematology & Oncology Physician compares to other specialties among Illinois providers

Illinois providers

Hematology & Oncology Physician share within Illinois

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Illinois

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

KELLIE FLIPPIN, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 1005 BROADWAY ST, QUINCY, IL, 62301, with a listed phone of (217) 223-8400. NPI 1013193705 was issued on 01/14/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FLIPPIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 536 prescription claims written by this provider, covering 114 Medicare beneficiaries and totaling roughly $892K in drug spend, split 27% brand-name and 73% generic by claim count, with an opioid prescribing rate of 6.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1005 BROADWAY ST
QUINCY, IL 62301

Provider Details

NPI 1013193705
Specialty Hematology & Oncology Physician
Credentials MD
Gender Female
NPI Issued 01/14/2008

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for KELLIE FLIPPIN, MD. Source: openpaymentsdata.cms.gov.

Total received

$15

Largest payer

Rigel Pharmaceuticals, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Illinois IDFPR 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~42K Illinois medical licensees in 2023 — they are NOT specific to KELLIE FLIPPIN, MD. To verify KELLIE FLIPPIN, MD's current license status, search the IDFPR public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

106
Total board actions, Illinois 2023
Across 103 cases
2.52
Actions per 1,000 licensees
Illinois statewide rate
probation
Most common action type
38 cases

IDFPR publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Illinois disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

KELLIE FLIPPIN, MD — brand share 27.0%
Specialty average (est.)

27% brand-name claims vs 73% generic, on 536 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

536
Total Claims
$892K
Total Drug Cost
114
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
841
Total Day Supply
22,421
Brand vs Generic
27% brand / 73% generic
Brand Drug Cost
$856K
Generic Drug Cost
$37K
Opioid Claims
33 (6.2% rate)
Antibiotic Claims
25

Patient Demographics

Average Patient Age
72.8 years
Avg HCC Risk Score
2.01
Gender Split
76% female / 24% male
Age Distribution
<65: 16, 65-74: 48, 75-84: 38, 85+: 12

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What KELLIE FLIPPIN, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Letrozole
64
Xarelto
Rivaroxaban
57
Anastrozole
41
Eliquis
Apixaban
33
Ondansetron Hcl
30
Tamoxifen Citrate
27
Prochlorperazine Maleate
22
Acyclovir
21
Omeprazole
16
Pomalyst
Pomalidomide
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How KELLIE FLIPPIN, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

KELLIE FLIPPIN, MD's 536 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Illinois

Other clinicians with the same primary specialty enrolled in Illinois, drawn from the same CMS NPPES roster as FLIPPIN.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is KELLIE FLIPPIN, MD's specialty?
KELLIE FLIPPIN, MD specializes in Hematology & Oncology Physician and practices in QUINCY, Illinois. Credentials: MD.
How much does KELLIE FLIPPIN, MD prescribe under Medicare Part D?
In 2023, KELLIE FLIPPIN, MD wrote 536 Medicare Part D claims totaling $892K in drug costs for 114 beneficiaries.
Where is KELLIE FLIPPIN, MD located?
KELLIE FLIPPIN, MD is located at 1005 BROADWAY ST, QUINCY, IL, 62301. Phone: (217) 223-8400.
What is KELLIE FLIPPIN, MD's NPI number?
KELLIE FLIPPIN, MD's National Provider Identifier (NPI) is 1013193705, issued on 01/14/2008.
Does KELLIE FLIPPIN, MD prescribe more brand-name or generic drugs?
KELLIE FLIPPIN, MD's prescribing is 27% brand-name and 73% generic drugs by claim count, with $856K in brand drug costs.
Does KELLIE FLIPPIN, MD prescribe opioids?
Yes, KELLIE FLIPPIN, MD had 33 opioid claims in 2023 with an opioid prescribing rate of 6.2%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does KELLIE FLIPPIN, MD prescribe most often?
Based on 2023 Medicare Part D data, KELLIE FLIPPIN, MD's most frequently prescribed drugs include Letrozole, Xarelto, Anastrozole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does KELLIE FLIPPIN, MD accept Medicare?
KELLIE FLIPPIN, MD appears in CMS Medicare data with 536 Part D claims and 114 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify KELLIE FLIPPIN, MD's credentials?
KELLIE FLIPPIN, MD's NPI is 1013193705 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology